Clinical Trial Update: Phase 2, Multiple Ascending Dose Proof of Concept Study [Phase 2]

View source ↗

Summary

Phase 2 multiple ascending dose proof-of-concept study completed for an infectious disease program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infectious Disease

Snippet

Sponsor: ContraVir Pharmaceuticals, Inc. | Conditions: Infectious Disease | Phase 2 | Status: COMPLETED